In a groundbreaking research presented at the IDWeek 2024, it was revealed that the detection of a multidrug-resistance gene was notably high amongst inpatients within a prominent New York health system, and was associated with significant fatality rates. The gene in focus, blaNDM, ranks among the top five carbapenemase genes most common in US hospitals.…